Drug intelligence / Profile preview

shenqimaixintong

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Shenqimaixintong (Shenqi Maixintong capsule, SMC) is a traditional Chinese medicine compound formulation used primarily for cardiovascular health. It is designed to nourish vitality (Qi), improve blood circulation, regulate vital energy, and promote coronary circulation. Preclinical and clinical studies suggest that SMC can alleviate atherosclerosis by reducing lipid accumulation in macrophages and modulating cholesterol metabolism. Mechanistically, it upregulates the expression of ABCA1, ABCG1, LXRα (Liver X receptor alpha), PPARα (Peroxisome proliferator-activated receptor alpha), and PPARγ while downregulating PCSK9 expression in response to oxidized low-density lipoprotein (ox-LDL) exposure. This results in reduced inflammation and improved lipid handling within vascular cells[1][5]. Clinical drug trials indicate that SMC acts as an antiatherosclerotic agent by blocking the TLR4/NF-κB signaling pathway and downregulating pro-inflammatory cytokines such as IL-6 and TNF-α[5].

Brand names
shenqimaixintong
Other names
Shenqi Maixintong capsuleSMCShenqi Maixintong
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)NF-κBPPARG (Peroxisome proliferator-activated receptor gamma)ABCG1 (ATP-binding cassette sub-family G member 1)TLR4 (Toll-like receptor 4)NR1H3 (Liver X receptor beta)ABCA1 (ATP-binding cassette transporter A1)

Beyond the preview

Go deeper on shenqimaixintong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenqimaixintong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call